German cannabis pain therapy trial sparks regulatory chaos, patients stranded

A German company's clinical trial purportedly shows cannabis effectively treats chronic back pain, but the government disputes the results, leaving patients without clear access. The core claim of efficacy is contested, and the regulatory response is unclear, creating uncertainty for patients and the medical cannabis market.